{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:55:42Z","timestamp":1794650142310,"version":"4.9.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007452","name":"Wu Jieping Medical Foundation","doi-asserted-by":"publisher","award":["32067502023-18-29"],"award-info":[{"award-number":["32067502023-18-29"]}],"id":[{"id":"10.13039\/100007452","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003395","name":"Shanghai Municipal Education Commission","doi-asserted-by":"publisher","award":["2023-05-50"],"award-info":[{"award-number":["2023-05-50"]}],"id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3404100"],"award-info":[{"award-number":["2023YFC3404100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC3404101"],"award-info":[{"award-number":["2023YFC3404101"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2506400"],"award-info":[{"award-number":["2023YFC2506400"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573797"],"award-info":[{"award-number":["82573797"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203860"],"award-info":[{"award-number":["82203860"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82325042"],"award-info":[{"award-number":["82325042"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xcrm.2026.102987","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:18:38Z","timestamp":1786634318000},"page":"102987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Spatial proteogenomic profiling uncovers sensitization strategies for antibody-drug conjugate in HER2-positive breast cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Yu-Wen","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Han","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Wu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ming","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Dong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2883-1282","authenticated-orcid":false,"given":"Ke-Da","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102987_bib1","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/S0140-6736(16)32417-5","article-title":"HER2-positive breast cancer","volume":"389","author":"Loibl","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102987_bib2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41571-019-0268-3","article-title":"HER2-targeted therapies - a role beyond breast cancer","volume":"17","author":"Oh","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102987_bib3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-022-00579-0","article-title":"Targeting HER2-positive breast cancer: advances and future directions","volume":"22","author":"Swain","year":"2023","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102987_bib4","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102987_bib5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa1914510","article-title":"Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer","volume":"382","author":"Modi","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102987_bib6","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1038\/s41591-022-01935-8","article-title":"Trastuzumab deruxtecan in HER2-positive breast cancer with brain metastases: a single-arm, phase 2 trial","volume":"28","author":"Bartsch","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102987_bib7","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.annonc.2023.04.516","article-title":"Patient-reported outcomes and hospitalization data in patients with HER2-positive metastatic breast cancer receiving trastuzumab deruxtecan or trastuzumab emtansine in the phase III DESTINY-Breast03 study","volume":"34","author":"Curigliano","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2026.102987_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0140-6736(22)02420-5","article-title":"Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial","volume":"401","author":"Hurvitz","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2026.102987_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.annonc.2025.10.019","article-title":"Neoadjuvant trastuzumab deruxtecan alone or followed by paclitaxel, trastuzumab, and pertuzumab for high-risk HER2-positive early breast cancer (DESTINY-Breast11): a randomised, open-label, multicentre, phase III trial","volume":"37","author":"Harbeck","year":"2026","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2026.102987_bib10","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.annonc.2025.02.011","article-title":"Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial","volume":"36","author":"Li","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2026.102987_bib11","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1200\/JCO.23.02044","article-title":"Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2-Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2-Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial","volume":"42","author":"Yao","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102987_bib12","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ccell.2025.03.017","article-title":"Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer","volume":"43","author":"Ma","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102987_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/s41592-025-02617-2","article-title":"Optimizing Xenium In Situ data utility by quality assessment and best-practice analysis workflows","volume":"22","author":"Marco Salas","year":"2025","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102987_bib14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nmeth.2869","article-title":"Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry","volume":"11","author":"Giesen","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102987_bib15","doi-asserted-by":"crossref","DOI":"10.1172\/JCI193793","article-title":"Macrophage transition to a myofibroblast state drives fibrotic disease in uropathogenic E. coli-induced epididymo-orchitis","volume":"135","author":"Wang","year":"2025","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102987_bib16","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1016\/j.cell.2024.04.023","article-title":"Osr2 functions as a biomechanical checkpoint to aggravate CD8(+) T cell exhaustion in tumor","volume":"187","author":"Zhang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102987_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155148","article-title":"Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-\u03b2 signaling enables PD-L1-mediated tumor eradication","volume":"132","author":"Horn","year":"2022","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102987_bib18","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1073\/pnas.1018892108","article-title":"Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors","volume":"108","author":"Diop-Frimpong","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102987_bib19","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s13346-018-00610-1","article-title":"Depletion of collagen by losartan to improve tumor accumulation and therapeutic efficacy of photodynamic nanoplatforms","volume":"9","author":"Tang","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.xcrm.2026.102987_bib20","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/s41588-022-01091-2","article-title":"Histone editing elucidates the functional roles of H3K27 methylation and acetylation in mammals","volume":"54","author":"Sankar","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2026.102987_bib21","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.molcel.2025.02.016","article-title":"Spatial control of m(6)A deposition on enhancer and promoter RNAs through co-acetylation of METTL3 and H3K27 on chromatin","volume":"85","author":"Huang","year":"2025","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2026.102987_bib22","doi-asserted-by":"crossref","first-page":"7759","DOI":"10.1038\/s41467-023-43519-1","article-title":"HDAC8-mediated inhibition of EP300 drives a transcriptional state that increases melanoma brain metastasis","volume":"14","author":"Emmons","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102987_bib23","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1007\/s00018-019-03074-9","article-title":"NEAT1 regulates neuroglial cell mediating A\u03b2 clearance via the epigenetic regulation of endocytosis-related genes expression","volume":"76","author":"Wang","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.xcrm.2026.102987_bib24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1470-2045(19)30164-0","article-title":"Tucidinostat plus exemestane for postmenopausal patients with advanced, hormone receptor-positive breast cancer (ACE): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Jiang","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2026.102987_bib25","article-title":"Neoadjuvant chidamide combined with chemotherapy in patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer (MUKDEN 05): a multicentre, single-arm, phase 2 trial","volume":"63","author":"Xue","year":"2025","journal-title":"Lancet Reg. Health West. Pac."},{"key":"10.1016\/j.xcrm.2026.102987_bib26","doi-asserted-by":"crossref","first-page":"21931","DOI":"10.1073\/pnas.1016071107","article-title":"Histone H3K27ac separates active from poised enhancers and predicts developmental state","volume":"107","author":"Creyghton","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102987_bib27","volume":"11","author":"Wu","year":"2026","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.xcrm.2026.102987_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.breast.2022.10.018","article-title":"Clinical outcomes of tucidinostat-based therapy after prior CDK4\/6 inhibitor progression in hormone receptor-positive heavily pretreated metastatic breast cancer","volume":"66","author":"Zhou","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.xcrm.2026.102987_bib29","doi-asserted-by":"crossref","DOI":"10.1172\/JCI176613","article-title":"Cancer-associated fibroblast-secreted collagen is associated with immune inhibitor receptor LAIR1 in gliomas","volume":"134","author":"Tripathi","year":"2024","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.xcrm.2026.102987_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122900","article-title":"Matrix stiffening from collagen fibril density and alignment modulates YAP-mediated T-cell immune suppression","volume":"315","author":"Sapudom","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.xcrm.2026.102987_bib31","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","article-title":"Spatial Positioning and Matrix Programs of Cancer-Associated Fibroblasts Promote T-cell Exclusion in Human Lung Tumors","volume":"12","author":"Grout","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102987_bib32","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300706120","article-title":"Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells","volume":"120","author":"Gu","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2026.102987_bib33","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s12951-024-02871-0","article-title":"Losartan-based nanocomposite hydrogel overcomes chemo-immunotherapy resistance by remodeling tumor mechanical microenvironment","volume":"22","author":"Hou","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.xcrm.2026.102987_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.biomaterials.2017.08.009","article-title":"Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple negative breast cancer","volume":"144","author":"Hu","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.xcrm.2026.102987_bib35","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231225032","article-title":"Rational and trial design of FASCINATE-N: a prospective, randomized, precision-based umbrella trial","volume":"16","author":"Zuo","year":"2024","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.xcrm.2026.102987_bib36","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1038\/s41596-023-00881-0","article-title":"An end-to-end workflow for multiplexed image processing and analysis","volume":"18","author":"Windhager","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.xcrm.2026.102987_bib37","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/s41592-019-0582-9","article-title":"ilastik: interactive machine learning for (bio)image analysis","volume":"16","author":"Berg","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102987_bib38","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","article-title":"CellProfiler 4: improvements in speed, utility and usability","volume":"22","author":"Stirling","year":"2021","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2026.102987_bib39","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1093\/bioinformatics\/btaa1061","article-title":"cytomapper: an R\/Bioconductor package for visualization of highly multiplexed imaging data","volume":"36","author":"Eling","year":"2021","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.102987_bib40","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1038\/s41592-019-0619-0","article-title":"Fast, sensitive and accurate integration of single-cell data with Harmony","volume":"16","author":"Korsunsky","year":"2019","journal-title":"Nat. Methods"},{"key":"10.1016\/j.xcrm.2026.102987_bib41","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1093\/bioinformatics\/btw313","article-title":"Complex heatmaps reveal patterns and correlations in multidimensional genomic data","volume":"32","author":"Gu","year":"2016","journal-title":"Bioinformatics"},{"key":"10.1016\/j.xcrm.2026.102987_bib42","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2018.07.010","article-title":"Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging","volume":"174","author":"Goltsev","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102987_bib43","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.cell.2020.07.005","article-title":"Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front","volume":"182","author":"Sch\u00fcrch","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102987_bib44","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nmeth.4391","article-title":"histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data","volume":"14","author":"Schapiro","year":"2017","journal-title":"Nat. Methods"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126004040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:45:21Z","timestamp":1789591521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126004040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2666379126004040"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102987","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spatial proteogenomic profiling uncovers sensitization strategies for antibody-drug conjugate in HER2-positive breast cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102987"}}